WPI 3171 Pill - white capsule/oblong, 10mm
Pill with imprint WPI 3171 is White, Capsule/Oblong and has been identified as Alendronate Sodium 35 mg. It is supplied by Watson Pharmaceuticals.
Alendronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis; Paget's Disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3171
Alendronate Sodium
- Imprint
- WPI 3171
- Strength
- 35 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-3171 (Discontinued)
- Inactive Ingredients
-
magnesium stearate,
mannitol,
microcrystalline cellulose,
sodium starch glycolate type A potato,
corn starch
Note: Inactive ingredients may vary.
More about alendronate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (181)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Alendronate drug information
- Alendronate (Advanced Reading)
- Alendronate Effervescent Tablets
- Alendronate Tablets
- Alendronate Oral Solution
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
